ACROBAT Edge: Safety and efficacy of switching injected SRLs to oral paltusotine in patients with acromegaly.
Mônica Roberto GadelhaMurray B GordonMirjana DoknicEmese MezősiMiklós TóthHarpal RandevaTonya MarmonTheresa JochelsonRosa LuoMichael MonahanAjay MadanChristine Ferrara-CookR Scott StruthersAlan KrasnerPublished in: The Journal of clinical endocrinology and metabolism (2022)
These results suggest once daily, oral paltusotine is effective in maintaining IGF-I values in patients with acromegaly who switched from injected SRLs. Paltusotine was well tolerated with a safety profile consistent with other SRLs.
Keyphrases